Pricing Log in Create free account

RenovoRx, Inc. (RNXT) vs Tenax Therapeutics, Inc. (TENX)

RenovoRx, Inc. and Tenax Therapeutics, Inc. are both Biotechnology companies. RenovoRx, Inc. and Tenax Therapeutics, Inc. are of similar size ($56.5M and $53.7M). Tenax Therapeutics, Inc. has the higher net margin (0.00% vs −621.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Tenax Therapeutics, Inc. leads on 8 and RenovoRx, Inc. on 6.

Valuation

Metric RNXT TENX Biotechnology median
P/E n/m n/m 8.50
P/S 27.53 201.11 9.71
P/B 6.06 0.61 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.71 0.64
EV/Sales 25.16 (141.75) 9.21
Earnings yield (26.96%) (108.82%) (33.15%)
Free cash flow yield (21.95%) (66.58%) (25.50%)

Profitability

Metric RNXT TENX Biotechnology median
Gross margin 84.41% 0.00% 65.16%
Operating margin (685.22%) 0.00% 0.00%
Net margin (621.71%) 0.00% 0.00%
Free cash flow margin (604.10%) 0.00% 0.00%
Return on equity (125.23%) (59.80%) (56.36%)
Return on assets (97.83%) (57.02%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric RNXT TENX Biotechnology median
Revenue growth (TTM) — (70.77%) 6.02%
EPS growth (last fiscal year) 20.00% (16.52%) 30.26%
Revenue growth, 5-year CAGR — 0.79% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric RNXT TENX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.74 15.07 4.72
Net debt to EBITDA 0.56 1.73 0.96

Dividend

Metric RNXT TENX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric RNXT TENX Biotechnology median
Market cap 53.71m 56.51m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack